119 related articles for article (PubMed ID: 20408759)
1. Oxidant production, oxLDL uptake, and CD36 levels in human monocyte–derived macrophages are downregulated by the macrophage-generated antioxidant 7,8-dihydroneopterin.
Gieseg SP; Amit Z; Yang YT; Shchepetkina A; Katouah H
Antioxid Redox Signal; 2010 Nov; 13(10):1525-34. PubMed ID: 20408759
[TBL] [Abstract][Full Text] [Related]
2. Effect of 7,8-dihydroneopterin mediated CD36 down regulation and oxidant scavenging on oxidised low-density lipoprotein induced cell death in human macrophages.
Shchepetkina AA; Hock BD; Miller A; Kennedy MA; Gieseg SP
Int J Biochem Cell Biol; 2017 Jun; 87():27-33. PubMed ID: 28356230
[TBL] [Abstract][Full Text] [Related]
3. OxLDL induced cell death is inhibited by the macrophage synthesised pterin, 7,8-dihydroneopterin, in U937 cells but not THP-1 cells.
Baird SK; Reid L; Hampton MB; Gieseg SP
Biochim Biophys Acta; 2005 Sep; 1745(3):361-9. PubMed ID: 16084608
[TBL] [Abstract][Full Text] [Related]
4. Foam cell formation but not oxLDL cytotoxicity is inhibited by CD36 down regulation by the macrophage antioxidant 7,8-dihydroneopterin.
Ghodsian N; Yeandle A; Gieseg SP
Int J Biochem Cell Biol; 2021 Apr; 133():105918. PubMed ID: 33421634
[TBL] [Abstract][Full Text] [Related]
5. Oxidised low density lipoprotein causes human macrophage cell death through oxidant generation and inhibition of key catabolic enzymes.
Katouah H; Chen A; Othman I; Gieseg SP
Int J Biochem Cell Biol; 2015 Oct; 67():34-42. PubMed ID: 26255116
[TBL] [Abstract][Full Text] [Related]
6. Macrophage mediated protein hydroperoxide formation and lipid oxidation in low density lipoprotein are inhibited by the inflammation marker 7,8-dihydroneopterin.
Firth CA; Crone EM; Flavall EA; Roake JA; Gieseg SP
Biochim Biophys Acta; 2008 Jun; 1783(6):1095-101. PubMed ID: 18342632
[TBL] [Abstract][Full Text] [Related]
7. Intracellular glutathione protects human monocyte-derived macrophages from hypochlorite damage.
Yang YT; Whiteman M; Gieseg SP
Life Sci; 2012 May; 90(17-18):682-8. PubMed ID: 22472425
[TBL] [Abstract][Full Text] [Related]
8. Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.
Gieseg SP; Crone EM; Flavall EA; Amit Z
Br J Pharmacol; 2008 Feb; 153(4):627-35. PubMed ID: 17700723
[TBL] [Abstract][Full Text] [Related]
9. CD36 down regulation by the macrophage antioxidant 7,8-dihydroneopterin through modulation of PPAR-γ activity.
Ghodsian N; Yeandle A; Hock BD; Gieseg SP
Free Radic Res; 2022; 56(5-6):366-377. PubMed ID: 36017639
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of THP-1 cell-mediated low-density lipoprotein oxidation by the macrophage-synthesised pterin, 7,8-dihydroneopterin.
Gieseg SP; Cato S
Redox Rep; 2003; 8(2):113-5. PubMed ID: 12804014
[TBL] [Abstract][Full Text] [Related]
11. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages.
Lian TW; Wang L; Lo YH; Huang IJ; Wu MJ
Biochim Biophys Acta; 2008 Oct; 1781(10):601-9. PubMed ID: 18662803
[TBL] [Abstract][Full Text] [Related]
12. Neopterin formation through radical scavenging of superoxide by the macrophage synthesised antioxidant 7,8-dihydroneopterin.
Baxter-Parker G; Prebble HM; Cross S; Steyn N; Shchepetkina A; Hock BD; Cousins A; Gieseg SP
Free Radic Biol Med; 2020 May; 152():142-151. PubMed ID: 32145301
[TBL] [Abstract][Full Text] [Related]
13. Modulation of LDL oxidation by 7,8-dihydroneopterin.
Greilberger J; Oettl K; Cvirn G; Reibnegger G; Jürgens G
Free Radic Res; 2004 Jan; 38(1):9-17. PubMed ID: 15061649
[TBL] [Abstract][Full Text] [Related]
14. Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression.
Dedoussis GV; Kaliora AC; Psarras S; Chiou A; Mylona A; Papadopoulos NG; Andrikopoulos NK
Atherosclerosis; 2004 Jun; 174(2):293-303. PubMed ID: 15136059
[TBL] [Abstract][Full Text] [Related]
15. 7,8 Dihydroneopterin inhibits low density lipoprotein oxidation in vitro. Evidence that this macrophage secreted pteridine is an anti-oxidant.
Gieseg SP; Reibnegger G; Wachter H; Esterbauer H
Free Radic Res; 1995 Aug; 23(2):123-36. PubMed ID: 7581810
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside transporters are critical to the uptake and antioxidant activity of 7,8-dihydroneopterin in monocytic cells.
Janmale TV; Lindsay A; Gieseg SP
Free Radic Res; 2020 May; 54(5):341-350. PubMed ID: 32375530
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3.
Wintergerst ES; Jelk J; Rahner C; Asmis R
Eur J Biochem; 2000 Oct; 267(19):6050-9. PubMed ID: 10998066
[TBL] [Abstract][Full Text] [Related]
18. Neopterin and 7,8-dihydroneopterin interfere with low density lipoprotein oxidation mediated by peroxynitrite and/or copper.
Herpfer I; Greilberger J; Ledinski G; Widner B; Fuchs D; Jürgens G
Free Radic Res; 2002 May; 36(5):509-20. PubMed ID: 12150539
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake.
Yang X; Yao H; Chen Y; Sun L; Li Y; Ma X; Duan S; Li X; Xiang R; Han J; Duan Y
J Biol Chem; 2015 Sep; 290(36):21788-99. PubMed ID: 26187465
[TBL] [Abstract][Full Text] [Related]
20. RRR-alpha-tocopherol decreases the expression of the major scavenger receptor, CD36, in human macrophages via inhibition of tyrosine kinase (Tyk2).
Venugopal SK; Devaraj S; Jialal I
Atherosclerosis; 2004 Aug; 175(2):213-20. PubMed ID: 15262176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
